Today, U.S. Representative Mike Quigley (IL-05), the lead sponsor of the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS), released a statement applauding the Senate's unanimous passage of the bipartisan, bicameral ACT for ALS:
"I am thrilled that the Senate has passed ACT for ALS and officially cleared the way for this life-saving, transformative legislation to be signed into law. For too long, the diagnosis of a neurodegenerative disease like ALS has been a death sentence that included the devastating hopelessness of no effective treatment options. ACT for ALS will finally help people living with this cruel disease access promising treatments and create the research infrastructure that could put a cure within reach.
"I am deeply grateful for the hard work and dedication of the Senate co-leads Senators Chris Coons and Lisa Murkowski and of my House co-lead Congressman Fortenberry. But, above all, I am grateful for the tireless advocacy of an entire community who has made the dream of this accomplishment a reality."